InvestLog
ALLO logo

ALLO

Allogene Therapeutics, Inc.NASDAQHealthcare
$2.48+4.84%ClosedMarket Cap: $604.6M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-13Canaccord Genuity—Buy—
2026-03-13Piper Sandler—Overweight—
2026-01-09Citizens—Market Outperform—
2025-10-10JP Morgan—Underweight—
2025-08-04JP Morgan—Neutral—
2025-08-04JMP Securities—Market Perform—
2025-08-01Oppenheimer—Outperform—
2025-05-15Citigroup—Buy—
2025-05-14Oppenheimer—Outperform—
2025-05-14RBC Capital—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.79$21.4M8
Sun Dec 31$-0.70$110.2M10
Mon Dec 31$-0.03$340.1M4
Tue Dec 31$0.90$646.0M4